cost-effectiveness analysis routine use isoniazid prophylaxis patients positive Mantoux skin test role isoniazid prophylaxis low-risk patients positive Mantoux skin tests general recent research risk/benefit ratio data cost-effectiveness analysis routine use isoniazid prophylaxis societal perspective Costs case low-risk patient positive Mantoux test base high low costings Rates use direct costs direct indirect costs Costs Canadian patient patient case direct costs costs direct indirect costs costs reasonable societal perspective issue increased life expectancy chemoprophylaxis 